Li Ka Shing-Backed Cancer Drug Developer Delays Launch of Hong Kong Listing

(Bloomberg) -- Hutchison China MediTech Ltd., a cancer drug developer backed by billionaire Li Ka-shing, is delaying the launch of its Hong Kong share sale that could raise about $500 million, peop...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.